It may be safe to omit stenting in some STEMI patients who have adequate flow restored and minimal residual stenosis, according to a look back at data from the DANAMI3-DEFER trial. Yet researchers ...
The preferred timing of treatment of nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) remains uncertain. A comparison of immediate percutaneous coronary ...
Giving half-dose thrombolytic to ST-elevation myocardial infarction (STEMI) patients who are going to have a delay in receiving primary percutaneous coronary intervention (PCI), provided effective ...
The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 ...
When reading the ECG of a patient presenting with cardiopulmonary complaints, the most important duty of acute care clinicians is to determine whether there is evidence of an acute coronary occlusion ...
Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation ...
Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says. STEMI (ST‐segment-elevation myocardial infarction) heart attacks have declined by nearly 50% during ...
PHOENIX -- Withdrawal of care was a common cause of death for ST-elevation myocardial infarction (STEMI) patients, with only rare use of palliative care, a single-center study showed. Overall, 24.6% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results